Evogene adds gene optimisation to Monsanto pact
The Israeli biotechnology company, Evogene (Rehovot), has incorporated its recently developed comprehensive gene optimisation programme into its multi-year collaboration with Monsanto. The programme is designed to optimise desired trait efficacy and potentially accelerate product development, Evogene points out. The addition of the programme follows the successful identification and validation by Evogene of more than 1,000 genes that have entered Monsanto's product development pipeline. The collaboration, which was initiated in 2008 and extended in 2013, focuses on transgenic approaches for improved yield and stress tolerance in maize, soybeans, cotton and canola.